Alnylam Pharma Names Yvonne Greenstreet President & COO - Quick Facts

(RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) announced that, Barry Greene, President, has decided to leave the company at the end of the third quarter. He will remain a consultant to the company for up to two years. The company has named Yvonne Greenstreet, currently Chief Operating Officer, as President and Chief Operating Officer effective October 1, 2020.

John Maraganore, CEO of Alnylam, said: "We respect his decision to pursue other interests. As we conduct the search for a Chief Commercial Officer, we anticipate no impact to our ongoing commercial execution."

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More